Trade BHVN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Biohaven Ltd. (BHVN) is trading at US$14.85, up 4.43% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$2.09B. Over the past 52 weeks, BHVN has traded between US$7.48 and US$18.57. On Syfe you can trade BHVN with $0 commission and add it to your watchlist.
| Previous close | US$14.22 |
|---|---|
| Market cap | US$2.09B |
| 52-week range | US$7.48 – US$18.57 |
| Volume | 2.43M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Biohaven Ltd.
Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
Year: 2022
Biohaven Ltd. (BHVN) stock is trading at US$14.85, +4.43% from the previous close of US$14.22.
The market cap for Biohaven Ltd. (BHVN) stock is approximately US$2.09B.
The 52-week high for Biohaven Ltd. (BHVN) stock is US$18.57.
The 52-week low for Biohaven Ltd. (BHVN) stock is US$7.48.
Biohaven Ltd. (BHVN) does not currently pay a dividend.
Stay on top of BHVN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
